PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
323 hedge funds and large institutions have $9.55B invested in PRA Health Sciences, Inc. in 2021 Q1 according to their latest regulatory filings, with 91 funds opening new positions, 91 increasing their positions, 112 reducing their positions, and 52 closing their positions.
75% more first-time investments, than exits
New positions opened: 91 | Existing positions closed: 52
21% more capital invested
Capital invested by funds: $7.9B → $9.55B (+$1.65B)
12% more funds holding
Funds holding: 289 → 323 (+34)
1.63% less ownership
Funds ownership: 98.16% → 96.53% (-1.6%)
19% less repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 112
86% less call options, than puts
Call options by funds: $3.6M | Put options by funds: $25.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$190M |
| 2 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$172M |
| 3 |
Citigroup
New York
|
+$135M |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$126M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$95.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$478M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$420M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$100M |
| 4 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$86.9M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$72.9M |
PRAH Hedge Fund Activity: Q1 2021 in Review
323 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q1 2021, worth a combined $9.55B — up 21% from $7.9B a quarter earlier.
Buyers outnumbered sellers: 91 funds opened new PRAH positions and 52 closed out — a net gain of 39 holders — while 91 added to existing stakes and 112 trimmed.
The largest buyer was Magnetar Financial, opening a new position worth an estimated $190M. The largest seller was T. Rowe Price Associates, cutting an estimated $478M.
- 323 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q1 2021, up from 289 in Q4 2020.
- Funds reported $9.55B of PRA Health Sciences, Inc. stock for Q1 2021, up 21% quarter-over-quarter.
- 91 funds opened new PRA Health Sciences, Inc. positions in Q1 2021 and 52 closed out, a net change of +39 holders.
- The largest PRA Health Sciences, Inc. buyer in Q1 2021 was Magnetar Financial, an estimated $190M added.
- The largest PRA Health Sciences, Inc. seller in Q1 2021 was T. Rowe Price Associates, an estimated $478M sold.
Based on aggregated 13F filings for Q1 2021.